Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Pharmacy staff profile

Professor Carlo Marra

PositionDean of the School of Pharmacy
QualificationsBSc(Pharm) PharmD PhD
Research summaryHealth outcomes including assessment of quality of life, preferences, and cost-effectiveness analyses

Research

Areas of interest include pharmacy practice research and formulary decision-making.

Professor Marra on Google Scholar

Publications

Raymakers, A. J. N., Sadatsafavi, M., Sin, D. D., FitzGerald, J. M., Marra, C. A., & Lynd, L. D. (2019). Inhaled corticosteroids and the risk of lung cancer in chronic obstructive pulmonary disease (COPD): A population-based cohort study. European Respiratory Journal. Advance online publication. doi: 10.1183/13993003.01257-2018

McCormick, N., Marra, C. A., Sadatsafavi, M., Kopec, J. A., & Aviña-Zubieta, J. A. (2019). Excess productivity costs of systemic lupus erythematosus, systemic sclerosis, and Sjögren's syndrome: A general population–based study. Arthritis Care & Research, 71(1), 142-154. doi: 10.1002/acr.23573

Al Hamarneh, Y. N., Johnston, K., Marra, C. A., & Tsuyuki, R. T. (2019). Pharmacist prescribing and care improves cardiovascular risk, but is it cost-effective? A cost-effectiveness analysis of the RxEACH study. Canadian Pharmacists Journal, 152(4), 257-265. doi: 10.1177/1715163519851822

Rizzardo, S., Bansback, N., Dragojlovic, N., Douglas, C., Li, K. H., Mitton, C., Marra, C., … Lynd, L. D. (2019). Evaluating Canadians’ values for drug coverage decision making. Value in Health, 22(3), 362-369. doi: 10.1016/j.jval.2018.08.008

McCormick, N., Marra, C. A., Sadatsafavi, M., & Aviña-Zubieta, J. A. (2019). Socioeconomic status at diagnosis influences the incremental direct medical costs of systemic lupus erythematosus: A longitudinal population-based study. Seminars in Arthritis & Rheumatism. Advance online publication. doi: 10.1016/j.semarthrit.2019.06.010

Chapter in Book - Research

Brooks, R., Coons, S. J., De Cock, P., Devlin, N., De Weert, W., Hansen, P., … Marra, C. (2003). EQ-5D in selected countries around the World. In R. Brooks, R. Rabin & F. de Charro (Eds.), The measurement and valuation of health status using the EQ-5D: A European perspective: Evidence from the EuroQol BIOMED Research Programme. (pp. 207-227). Kluwer. doi: 10.1007/978-94-017-0233-1_13

^ Top of page

Journal - Research Article

Raymakers, A. J. N., Sadatsafavi, M., Sin, D. D., FitzGerald, J. M., Marra, C. A., & Lynd, L. D. (2019). Inhaled corticosteroids and the risk of lung cancer in chronic obstructive pulmonary disease (COPD): A population-based cohort study. European Respiratory Journal. Advance online publication. doi: 10.1183/13993003.01257-2018

McCormick, N., Marra, C. A., Sadatsafavi, M., & Aviña-Zubieta, J. A. (2019). Socioeconomic status at diagnosis influences the incremental direct medical costs of systemic lupus erythematosus: A longitudinal population-based study. Seminars in Arthritis & Rheumatism. Advance online publication. doi: 10.1016/j.semarthrit.2019.06.010

Rizzardo, S., Bansback, N., Dragojlovic, N., Douglas, C., Li, K. H., Mitton, C., Marra, C., … Lynd, L. D. (2019). Evaluating Canadians’ values for drug coverage decision making. Value in Health, 22(3), 362-369. doi: 10.1016/j.jval.2018.08.008

Al Hamarneh, Y. N., Johnston, K., Marra, C. A., & Tsuyuki, R. T. (2019). Pharmacist prescribing and care improves cardiovascular risk, but is it cost-effective? A cost-effectiveness analysis of the RxEACH study. Canadian Pharmacists Journal, 152(4), 257-265. doi: 10.1177/1715163519851822

McCormick, N., Marra, C. A., Sadatsafavi, M., Kopec, J. A., & Aviña-Zubieta, J. A. (2019). Excess productivity costs of systemic lupus erythematosus, systemic sclerosis, and Sjögren's syndrome: A general population–based study. Arthritis Care & Research, 71(1), 142-154. doi: 10.1002/acr.23573

Donnan, J. R., Johnston, K., Chibrikov, E., Marra, C. A., Aubrey-Bassler, K., Najafzadeh, M., … Gamble, J.-M. (2019). Capturing patient preferences towards benefits and risks of second-line antihyperglycemic medications: A discrete choice experiment. Canadian Journal of Diabetes. Advance online publication. doi: 10.1016/j.jcjd.2019.04.014

Donnan, J. R., Grandy, C. A., Chibrikov, E., Marra, C. A., Aubrey-Bassler, K., Johnston, K., … Gamble, J.-M. (2019). Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: A systematic review and meta-analysis. BMJ Open, 9(1), e022577. doi: 10.1136/bmjopen-2018-022577

Salmasi, S., Tsao, N. W., Li, K., Shaske, J. N., Marra, C. A., & Lynd, L. D. (2019). Characterization of pharmacist-based medication management services in a community pharmacy. Research in Social & Administrative Pharmacy. Advance online publication. doi: 10.1016/j.sapharm.2019.04.051

De Vera, M. A., Campbell, N. K. J., Chhina, H., Galo, J. S., & Marra, C. (2018). Practical strategies and perceptions from community pharmacists following their experiences with conducting pharmacy practice research: A qualitative content analysis. International Journal of Pharmacy Practice, 26(4), 302-309. doi: 10.1111/ijpp.12409

Lynd, L. D., Henrich, N. J., Hategeka, C., Marra, C. A., Mittmann, N., Evans, C., & Traboulsee, A. L. (2018). Perspectives of patients with multiple sclerosis on drug treatment: A qualitative study. International Journal of MS Care, 20(6), 269-277. doi: 10.7224/1537-2073.2017-109

Tsao, N. W., Sayre, E. C., Hanley, G., Sadatsafavi, M., Lynd, L. D., Marra, C. A., & De Vera, M. A. (2018). Risk of preterm delivery and small-for-gestational-age births in women with autoimmune disease using biologics before or during pregnancy: A population-based cohort study. Annals of the Rheumatic Diseases, 77(6), 869-874. doi: 10.1136/annrheumdis-2018-213023

van der Kop, M. L., Muhula, S., Nagide, P. I., Thabane, L., Gelmon, L., Awiti, P. O., … Marra, C., … Lester, R. T. (2018). Effect of an interactive text-messaging service on patient retention during the first year of HIV care in Kenya (WelTel Retain): An open-label, randomised parallel-group study. Lancet Public Health, 3, e143-e152. doi: 10.1016/S2468-2667(17)30239-6

Rai, S. K., Howren, A., Wilcox, E. S., Townsend, A. F., Marra, C. A., Aviña-Zubieta, J. A., & De Vera, M. A. (2018). Exploring strategies to support medication adherence in patients with inflammatory arthritis: A patient-oriented qualitative study using an interactive focus group activity. Patient Preference & Adherence, 12, 2015-2025. doi: 10.2147/ppa.S174672

Donnan, J. R., Grandy, C. A., Chibrikov, E., Marra, C., Aubrey-Bassler, K., Johnston, K., … Gamble, J.-M. (2018). Dose response of sodium glucose cotransporter-2 inhibitors in relation to urinary tract infections: A systematic review and network meta-analysis of randomized controlled trials. CMAJ Open, 6(4), e594-e602. doi: 10.9778/cmajo.20180111

Khakban, A., Mohammadi, T., Lynd, L. D., Mabbott, D. J., Bouffet, E., Gastonguay, L., … Marra, C. A. (2018). How do parents and providers trade-off between disability and survival? Preferences in the treatment of pediatric medulloblastoma. Patient Preference & Adherence, 12, 2103-2110. doi: 10.2147/ppa.S168739

Duffull, S. B., Wright, D. F. B., Marra, C. A., & Anakin, M. G. (2018). A philosophical framework for pharmacy in the 21st century guided by ethical principles. Research in Social & Administrative Pharmacy, 14(3), 309-316. doi: 10.1016/j.sapharm.2017.04.049

Mohammadi, T., Bansback, N., Marra, F., Khakban, A., Campbell, J. R., FitzGerald, J. M., … Marra, C. A. (2017). Testing the external validity of a discrete choice experiment method: An application to latent tuberculosis infection treatment. Value in Health, 20(7), 969-975. doi: 10.1016/j.jval.2017.04.007

Marra, C., Johnston, K., Santschi, V., & Tsuyuki, R. T. (2017). Cost-effectiveness of pharmacist care for managing hypertension in Canada. Canadian Pharmacists Journal, 150(3), 184-197. doi: 10.1177/1715163517701109

Raymakers, A. J. N., McCormick, N., Marra, C. A., Fitzgerald, J. M., Sin, D., & Lynd, L. D. (2017). Do inhaled corticosteroids protect against lung cancer in patients with COPD? A systematic review. Respirology, 22(1), 61-70. doi: 10.1111/resp.12919

Khakban, A., Mohammadi, T., Lynd, L. D., Mabbott, D., Bouffet, E., Gastonguay, L., … Marra, C. A. (2017). Societal preferences in the treatment of pediatric medulloblastoma: Balancing risk of death and quality of life. Pediatric Blood & Cancer, 64(6), e26340. doi: 10.1002/pbc.26340

Patel, A. R., Lester, R. T., Marra, C. A., van der Kop, M. L., Ritvo, P., Engel, L., … Lynd, L. D. (2017). The validity of the SF-12 and SF-6D instruments in people living with HIV/AIDS in Kenya. Health & Quality of Life Outcomes, 15(1), 143. doi: 10.1186/s12955-017-0708-7

McCormick, N., Reimer, K., Famouri, A., Marra, C. A., & Aviña-Zubieta, J. A. (2017). Filling the gaps in SARDs research: Collection and linkage of administrative health data and self-reported survey data for a general population-based cohort of individuals with and without diagnoses of systemic autoimmune rheumatic disease (SARDs) from British Columbia, Canada. BMJ Open, 7, e013977. doi: 10.1136/bmjopen-2016-013977

Marra, C. A., Harvard, S., Grubisic, M., Galo, J., Clarke, A., Elliott, S., & Lynd, L. D. (2017). Consumer preferences for food allergen labeling. Allergy, Asthma & Clinical Immunology, 13, 19. doi: 10.1186/s13223-017-0189-6

Patel, A. R., Kessler, J., Braithwaite, S., Nucifora, K. A., Thirumurthy, H., Zhou, Q., … Marra, C. A. (2017). Economic evaluation of mobile phone text message interventions to improve adherence to HIV therapy in Kenya. Medicine, 96(7), e6078. doi: 10.1097/MD.0000000000006078

Tsao, N. W., Lynd, L. D., Gastonguay, L., Li, K., Nakagawa, B., & Marra, C. A. (2016). Factors associated with pharmacists’ perceptions of their working conditions and safety and effectiveness of patient care. Canadian Pharmacists Journal, 149(1), 18-27. doi: 10.1177/1715163515617777

Chen, W., Marra, C. A., Lynd, L. D., FitzGerald, J. M., Zafari, Z., & Sadatsafavi, M. (2016). The natural history of severe asthma and influences of early risk factors: A population-based cohort study. Thorax, 71(3), 267-275. doi: 10.1136/thoraxjnl-2015-207530

Leung, V. W. Y., Soon, J. A., Lynd, L. D., Marra, C. A., & Levine, M. (2016). Population-based evaluation of the effectiveness of two regimens for emergency contraception. International Journal of Gynecology & Obstetrics, 133(3), 342-346. doi: 10.1016/j.ijgo.2015.10.017

Chen, W., Lynd, L. D., FitzGerald, J. M., Marra, C. A., Balshaw, R., To, T., … for the Canadian Respiratory Research Network. (2016). Excess medical costs in patients with asthma and the role of comorbidity. European Respiratory Journal, 48(6), 1584-1592. doi: 10.1183/13993003.01141-2016

Zafari, Z., Sadatsafavi, M., Marra, C. A., Chen, W., & Fitzgerald, J. M. (2016). Cost-effectiveness of bronchial thermoplasty, omalizumab, and standard therapy for moderate-to-severe allergic asthma. PLoS ONE, 11(1), e0146003. doi: 10.1371/journal.pone.0146003

Rosenthal, M., Tsao, N. W., Tsuyuki, R. T., & Marra, C. A. (2016). Identifying relationships between the professional culture of pharmacy, pharmacists' personality traits, and the provision of advanced pharmacy services. Research in Social & Administrative Pharmacy, 12(1), 56-67. doi: 10.1016/j.sapharm.2015.05.003

Davis, J. C., Dian, L., Khan, K. M., Bryan, S., Marra, C. A., Hsu, C. L., … Liu-Ambrose, T. (2016). Cognitive status is a determinant of health resource utilization among individuals with a history of falls: A 12-month prospective cohort study. Osteoporosis International, 27(3), 943-951. doi: 10.1007/s00198-015-3350-4

Bansback, N., Harrison, M., & Marra, C. (2016). Does introducing imprecision around probabilities for benefit and harm influence the way people value treatments? Medical Decision Making, 36(4), 490-502. doi: 10.1177/0272989X15600708

van Dijk, W., Tan, W., Li, P., Guo, B., Li, S., Benedetti, A., … CanCOLD Study Group, including Marra, C. (2015). Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: Patient-reported outcomes from the CanCOLD cohort. Annals of Family Medicine, 13(1), 41-48. doi: 10.1370/afm.1714

van Karnebeek, C. D. M., Mohammadi, T., Tsao, N., Sinclair, G., Sirrs, S., Stockler, S., & Marra, C. (2015). Health economic evaluation of plasma oxysterol screening in the diagnosis of Niemann-Pick Type C disease among intellectually disabled using discrete event simulation. Molecular Genetics & Metabolism, 114(2), 226-232. doi: 10.1016/j.ymgme.2014.07.004

Trenaman, L., Sadatsafavi, M., Almeida, F., Ayas, N., Lynd, L., Marra, C., … Barnsback, N. (2015). Exploring the potential cost-effectiveness of patient decision aids for use in adults with obstructive sleep apnea: A case study. Medical Decision Making, 35(5), 671-682. doi: 10.1177/0272989X14556676

Chen, W., Lynd, L. D., Fitzgerald, J. M., Marra, C. A., Rousseau, R., & Sadatsafavi, M. (2015). The added effect of comorbidity on health-related quality of life in patients with asthma. Quality of Life Research, 24(10), 2507-2517. doi: 10.1007/s11136-015-0995-6

Khan, K. M., Windt, A., Davis, J. C., Dawes, M., Liu-Ambrose, T., Madden, K., Marra, C. A., … Adams, D. J. (2015). Group Medical Visits (GMVs) in primary care: An RCT of group-based versus individual appointments to reduce HbA1c in older people. BMJ Open, 5(7), e007441. doi: 10.1136/bmjopen-2014-007441

Davis, J. C., Bryan, S., Marra, C. A., Hsiung, G.-Y. R., & Liu-Ambrose, T. (2015). Challenges with cost-utility analyses of behavioural interventions among older adults at risk for dementia. British Journal of Sports Medicine, 49(20), 1343-1347. doi: 10.1136/bjsports-2013-092743

O'Hara, N. N., Roy, L., O'Hara, L. M., Spiegel, J. M., Lynd, L. D., Fitzgerald, J. M., … Marra, C. A. (2015). Healthcare worker preferences for active tuberculosis case finding programs in South Africa: A best-worst scaling choice experiment. PLoS ONE, 10(7), e0133304. doi: 10.1371/journal.pone.0133304

Tsao, N. W., Khakban, A., Gastonguay, L., Li, K., Lynd, L. D., & Marra, C. A. (2015). Perceptions of British Columbia residents and their willingness to pay for medication management services provided by pharmacists. Canadian Pharmacists Journal, 148(5), 263-273. doi: 10.1177/1715163515597244

Harrison, M., Marra, C., Shojania, K., & Bansback, N. (2015). Societal preferences for rheumatoid arthritis treatments: Evidence from a discrete choice experiment. Rheumatology, 54(10), 1816-1825. doi: 10.1093/rheumatology/kev113

Khakban, A., Fitzgerald, J. M., Ng, R., Zafari, Z., McManus, B., Hollander, Z., Marra, C. A., & Sadatsafavi, M. (2015). Ten-year trends in direct costs of COPD: A population-based study. Chest, 148(3), 640-646. doi: 10.1378/chest.15-0721

Law, M. R., Cheng, L., Kratzer, J., Morgan, S. G., Marra, C., Lynd, L. D., & Majumdar, S. R. (2015). Impact of allowing pharmacists to independently renew prescriptions: A population-based study. Journal of the American Pharmacists Association, 55(4), 398-404. doi: 10.1331/JAPhA.2015.14262

Henrich, N., Tsao, N., Gastonguay, L., Lynd, L., & Marra, C. A. (2015). BC Medication Management Project: Perspectives of pharmacists, patients and physicians. Canadian Pharmacists Journal, 148(2), 90-100. doi: 10.1177/1715163515569571

Dragojlovic, N., Rizzardo, S., Bansback, N., Mitton, C., Marra, C. A., & Lynd, L. D. (2015). Challenges in measuring the societal value of orphan drugs: Insights from a Canadian stated preference survey. Patient, 8(1), 93-101. doi: 10.1007/s40271-014-0109-5

Tsao, N. W., Marra, C. A., Lynd, L. D., Thomas, J. M., & Ferreira, E. (2014). Community pharmacist surveillance of hypertension in pregnancy: Are we ready for prime time? Canadian Pharmacists Journal, 147(5), 307-315. doi: 10.1177/1715163514543898

Raymakers, A. J. N., Mayo, J., Marra, C. A., & Fitzgerald, M. (2014). Diagnostic strategies incorporating computed tomography angiography for pulmonary embolism: A systematic review of cost-effectiveness analyses. Journal of Thoracic Imaging, 29(4), 209-216. doi: 10.1097/RTI.0b013e3182999e41

Marra, F., Kaczorowski, J., Gastonguay, L., Marra, C. A., & Lynd, L. D. (2014). Pharmacy-based Immunization in rural Communities Strategy (PhICS): A community cluster-randomized trial. Canadian Pharmacists Journal, 147(1), 33-44. doi: 10.1177/1715163513514020

Zafari, Z., Thorlund, K., Fitzgerald, J. M., Marra, C. A., & Sadatsafavi, M. (2014). Network vs. pairwise meta-analyses: A case study of the impact of an evidence-synthesis paradigm on value of information outcomes. Pharmacoeconomics, 32(10), 995-1004. doi: 10.1007/s40273-014-0179-1

Sadatsafavi, M., Marra, C., Aaron, S., & Bryan, S. (2014). Incorporating external evidence in trial-based cost-effectiveness analyses: The use of resampling methods. Trials, 15(1), 201. doi: 10.1186/1745-6215-15-201

Tsao, N. W., Shojania, K., & Marra, C. (2014). Cost-effectiveness of abatacept for moderate-to-severe rheumatoid arthritis. Expert Review of Pharmacoeconomics & Outcomes Research, 14(1), 9-18. doi: 10.1586/14737167.2014.861742

Sadatsafavi, M., Lynd, L. D., Marra, C. A., & Fitzgerald, J. M. (2014). Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: A population-based study. Thorax, 69(4), 328-334. doi: 10.1136/thoraxjnl-2013-203998

Henrich, N., Marra, C. A., Gastonguay, L., Mabbott, D., Malkin, D., Fryer, C., … Lynd, L. (2014). De-escalation of therapy for pediatric medulloblastoma: Trade-offs between quality of life and survival. Pediatric Blood & Cancer, 61(7), 1300-1304. doi: 10.1002/pbc.24990

Marra, C. A., Grubisic, M., Cibere, J., Grindrod, K. A., Woolcott, J. C., Gastonguay, L., & Esdaile, J. M. (2014). Cost-utility analysis of a multidisciplinary strategy to manage osteoarthritis of the knee: Economic evaluation of a cluster randomized controlled trial study. Arthritis Care & Research, 66(6), 810-816. doi: 10.1002/acr.22232

Levin, D., Bell, S., Sund, R., Hartikainen, S. A., Tuomilehto, J., Pukkala, E., … Marra, C., … on behalf of the Scottish Diabetes Research Network Epidemiology Group, and the Diabetes and Cancer Research Consortium. (2014). Pioglitazone and bladder cancer risk: A multipopulation pooled, cumulative exposure analysis. Diabetologia, 58(3), 493-504. doi: 10.1007/s00125-014-3456-9

Sadatsafavi, M., Marra, C., Marra, F., Moran, O., Fitzgerald, J. M., & Lynd, L. (2013). A quantitative benefit-risk analysis of isoniazid for treatment of latent tuberculosis infection using incremental benefit framework. Value in Health, 16(1), 66-75. doi: 10.1016/j.jval.2012.09.006

Najafzadeh, M., Davis, J. C., Joshi, P., & Marra, C. (2013). Barriers for integrating personalized medicine into clinical practice: A qualitative analysis. American Journal of Medical Genetics Part A, 161A(4), 758-763. doi: 10.1002/ajmg.a.35811

Sadatsafavi, M., Fitzgerald, M., Marra, C., & Lynd, L. (2013). Costs and health outcomes associated with primary vs secondary care after an asthma-related hospitalization: A population-based study. Chest, 144(2), 428-435. doi: 10.1378/chest.12-2773

Sweeney, K., Grubisic, M., Marra, C. A., Kendall, R., Li, L. C., & Lynd, L. D. (2013). Comparison of HRQL between unicompartmental knee arthroplasty and total knee arthroplasty for the treatment of osteoarthritis. Journal of Arthroplasty, 28(Suppl. 2), 187-190. doi: 10.1016/j.arth.2013.05.009

Davis, J. C., Bryan, S., Marra, C. A., Sharma, D., Chan, A., Beattie, B. L., … Liu-Ambrose, T. (2013). An economic evaluation of resistance training and aerobic training versus balance and toning exercises in older adults with mild cognitive impairment. PLoS ONE, 8(5), e63031. doi: 10.1371/journal.pone.0063031

van der Kop, M. L., Ojakaa, D. I., Patel, A., Thabane, L., Kinagwi, K., Ekström, A. M., … Marra, C., … Lester, R. T. (2013). The effect of weekly short message service communication on patient retention in care in the first year after HIV diagnosis: Study protocol for a randomised controlled trial (WelTel Retain). BMJ Open, 3(6), e003155. doi: 10.1136/bmjopen-2013-003155

Sadatsafavi, M., Lynd, L., Marra, C., Bedouch, P., & Fitzgerald, M. (2013). Comparative outcomes of leukotriene receptor antagonists and long-acting β-agonists as add-on therapy in asthmatic patients: A population-based study. Journal of Allergy & Clinical Immunology, 132(1), 63-69. doi: 10.1016/j.jaci.2013.02.007

Sadatsafavi, M., Barnsback, N., Zafari, Z., Najafzadeh, M., & Marra, C. (2013). Need for speed: An efficient algorithm for calculation of single-parameter expected value of partial perfect information. Value in Health, 16(2), 438-448. doi: 10.1016/j.jval.2012.10.018

Almeida, F. R., Henrich, N., Marra, C., Lynd, L. D., Lowe, A. A., Tsuda, H., … Ayas, N. (2013). Patient preferences and experiences of CPAP and oral appliances for the treatment of obstructive sleep apnea: A qualitative analysis. Sleep & Breathing, 17(2), 659-666. doi: 10.1007/s11325-012-0739-6

Marra, F., Young, F., Richardson, K., & Marra, C. A. (2013). A meta-analysis of intradermal versus intramuscular influenza vaccines: Immunogenicity and adverse events. Influenza & Other Respiratory Viruses, 7(4), 584-603. doi: 10.1111/irv.12000

Sadatsafavi, M., Marra, C., & Bryan, S. (2013). Two-level resampling as a novel method for the calculation of the expected value of sample information in economic trials. Health Economics, 22(7), 877-882. doi: 10.1002/hec.2869

Davis, E. M., Lynd, L. D., Grubisic, M., Kopec, J. A., Sayre, E. C., Cibere, J., … Marra, C. A. (2013). Responsiveness of health state utility values in knee osteoarthritis. Journal of Rheumatology, 40(12), 2075-2082. doi: 10.3899/jrheum.130176

Colmers, I. N., Majumdar, S. R., Yasui, Y., Bowker, S. L., Marra, C. A., & Johnson, J. A. (2013). Detection bias and overestimation of bladder cancer risk in type 2 diabetes: A matched cohort study. Diabetes Care, 36(10), 3070-3075. doi: 10.2337/dc13-0045

Najafzadeh, M., Johnston, K. M., Peacock, S. J., Connors, J. M., Marra, M. A., Lynd, L. D., & Marra, C. A. (2013). Genomic testing to determine drug response: Measuring preferences of the public and patients using Discrete Choice Experiment (DCE). BMC Health Services Research, 13(1), 454. doi: 10.1186/1472-6963-13-454

Sadatsafavi, M., Ganjizadeh, S., Hatala, R., Marra, C., & Fitzgerald, M. (2012). The "Lost NNT" can be used to represent uncertainty surrounding number needed to treat. Journal of Clinical Epidemiology, 65(8), 863-868. doi: 10.1016/j.jclinepi.2012.01.022

Najafzadeh, M., Lynd, L. D., Davis, J. C., Bryan, S., Anis, A., Marra, M., & Marra, C. A. (2012). Barriers to integrating personalized medicine into clinical practice: A best-worst scaling choice experiment. Genetics in Medicine, 14(5), 520-526. doi: 10.1038/gim.2011.26

Slobogean, G. P., Marra, C. A., Sadatsafavi, M., Sanders, D. W., on behalf of the Canadian Orthopedic Trauma Society. (2012). Is surgical fixation for stress-positive unstable ankle fractures cost effective? Results of a multicenter randomized control trial. Journal of Orthopaedic Trauma, 26(11), 652-658. doi: 10.1097/BOT.0b013e31824aec42

Raymakers, A. J. N., Sadatsafavi, M., Marra, F., & Marra, C. A. (2012). Economic and humanistic burden of external genital warts. Pharmacoeconomics, 30(1), 1-16. doi: 10.2165/11591170-000000000-00000

Woolcott, J. C., Khan, K. M., Mitrovic, S., Anis, A. H., & Marra, C. A. (2012). The cost of fall related presentations to the ED: A prospective, in-person, patient-tracking analysis of health resource utilization. Osteoporosis International, 23(5), 1513-1519. doi: 10.1007/s00198-011-1764-1

Tsao, N. W., Barnsback, N. J., Shojania, K., & Marra, C. A. (2012). The issue of comparators in economic evaluations of biologic response modifiers in rheumatoid arthritis. Best Practice & Research: Clinical Rheumatology, 26(5), 659-676. doi: 10.1016/j.berh.2012.07.012

Najafzadeh, M., Marra, C. A., Lynd, L. D., & Wiseman, S. M. (2012). Cost-effectiveness of using a molecular diagnostic test to improve preoperative diagnosis of thyroid cancer. Value in Health, 15(8), 1005-1013. doi: 10.1016/j.jval.2012.06.017

Najafzadeh, M., Marra, C. A., Lynd, L. D., Sadatsafavi, M., Fitzgerald, J. M., McManus, B., & Sin, D. (2012). Future impact of various interventions on the burden of COPD in Canada: A dynamic population model. PLoS ONE, 7(10), e46746. doi: 10.1371/journal.pone.0046746

Marra, C. A., Cibere, J., Grubisic, M., Grindrod, K. A., Gastonguay, L., Thomas, J. M., … Esdaile, J. M. (2012). Pharmacist-initiated intervention trial in osteoarthritis: A multidisciplinary intervention for knee osteoarthritis. Arthritis Care & Research, 64(12), 1837-1845. doi: 10.1002/acr.21763

Marra, C. A., Lynd, L. D., Grindrod, K. A., Joshi, P., & Isakovic, A. (2012). Evaluating the labour costs associated with pharmacy adaptation services in British Columbia. Canadian Pharmacists Journal, 145(2), 78-82. doi: 10.3821/145.2.cpj78

Marra, C. A., Lynd, L. D., Colley, L., Harvard, S. S., Lacaille, D., Schwenger, E., … Esdaile, J. M. (2012). Risk of gastrointestinal events in patients with rheumatoid arthritis after withdrawal of rofecoxib. Journal of Rheumatology, 39(5), 910-915. doi: 10.3899/jrheum.110604

van der Kop, M. L., Karanja, S., Thabane, L., Marra, C., Chung, M. H., Gelmon, L., … Lester, R. T. (2012). In-depth analysis of patient-clinician cell phone communication during the WelTel Kenya1 antiretroviral adherence trial. PLoS ONE, 7(9), e46033. doi: 10.1371/journal.pone.0046033

Bedouch, P., Sadatsafavi, M., Marra, C. A., Fitzgerald, J. M., & Lynd, L. D. (2012). Trends in asthma-related direct medical costs from 2002 to 2007 in British Columbia, Canada: A population based-cohort study. PLoS ONE, 7(12), e50949. doi: 10.1371/journal.pone.0050949

Seto, K., Marra, F., Raymakers, A., & Marra, C. A. (2012). The cost effectiveness of human papillomavirus vaccines: A systematic review. Drugs, 72(5), 715-743. doi: 10.2165/11599470-000000000-00000

Davis, J. C., Liu-Ambrose, T., Khan, K. M., Robertson, M. C., & Marra, C. A. (2012). SF-6D and EQ-5D result in widely divergent incremental cost-effectiveness ratios in a clinical trial of older women: Implications for health policy decisions. Osteoporosis International, 23(7), 1849-1857. doi: 10.1007/s00198-011-1770-3

Marra, C. A., Bansback, N., Anis, A. H., & Shojania, K. (2011). Introduction to economic modeling for clinical rheumatologists: Application to biologic agents in rheumatoid arthritis. Clinical Rheumatology, 30(Suppl.1), S9-S18. doi: 10.1007/s10067-010-1635-8

Wilby, K., Marra, C. A., da Silva, J. H., Grubisic, M., Harvard, S., & Lynd, L. D. (2011). Randomized controlled trial evaluating pictogram augmentation of HIV medication information. Annals of Pharmacotherapy, 45(11), 1378-1383. doi: 10.1345/aph.1Q091

Anis, A., Harvard, S., & Marra, C. (2011). Ontario's plunging price-caps on generics: Deeper dives may drown some drugs. Open Medicine, 5(3), E149-E153.

Marra, F., Marra, C. A., Richardson, K., Lynd, L. D., & FitzGerald, M. J. (2011). Antibiotic consumption in children prior to diagnosis of asthma. BMC Pulmonary Medicine, 11, 32. doi: 10.1186/1471-2466-11-32

Davis, J. C., Marra, C. A., Robertson, M. C., Khan, K. M., Najafzadeh, M., Ashe, M. C., & Liu-Ambrose, T. (2011). Economic evaluation of dose-response resistance training in older women: A cost-effectiveness and cost-utility analysis. Osteoporosis International, 22(5), 1355-1366. doi: 10.1007/s00198-010-1356-5

Davis, J. C., Marra, C. A., Robertson, M. C., Najafzadeh, M., & Liu-Ambrose, T. (2011). Sustained economic benefits of resistance training in community-dwelling senior women. Journal of the American Geriatrics Society, 59(7), 1232-1237. doi: 10.1111/j.1532-5415.2011.03474.x

Guo, N., Marra, C. A., Fitzgerald, M., Elwood, R. K., Anis, A. H., & Marra, F. (2011). Patient preference for latent tuberculosis infection preventive treatment: A discrete choice experiment. Value in Health, 14(6), 937-943. doi: 10.1016/j.jval.2011.05.003

Bowker, S. L., Richardson, K., Marra, C. A., & Johnson, J. A. (2011). Risk of breast cancer after onset of type 2 diabetes: Evidence of detection bias in postmenopausal women. Diabetes Care, 34(12), 2542-2544. doi: 10.2337/dc11-1199

Davis, J. C., Marra, C. A., & Liu-Ambrose, T. (2011). Falls-related self-efficacy is independently associated with quality-adjusted life years in older women. Age & Ageing, 40(3), 340-346. doi: 10.1093/ageing/afr019

Oteng, B., Marra, F., Lynd, L. D., Ogilvie, G., Patrick, D., & Marra, C. A. (2011). Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme. Sexually Transmitted Infections, 87(1), 52-57. doi: 10.1136/sti.2009.041392

Henrich, N., Joshi, P., Grindrod, K., Lynd, L., & Marra, C. (2011). Family physicians' perceptions of pharmacy adaptation services in British Columbia. Canadian Pharmacists Journal, 144(4), 172-178. doi: 10.3821/1913-701X-144.4.172

Johnson, J. A., Bowker, S. L., Richardson, K., & Marra, C. A. (2011). Time-varying incidence of cancer after the onset of type 2 diabetes: Evidence of potential detection bias. Diabetologia, 54(9), 2263-2271. doi: 10.1007/s00125-011-2242-1

Marra, C. A., Lynd, L. D., Harvard, S. S., & Grubisic, M. (2011). Agreement between aggregate and individual-level measures of income and education: A comparison across three patient groups. BMC Health Services Research, 11, 69. doi: 10.1186/1472-6963-11-69

Grindrod, K. A., Lynd, L. D., Joshi, P., Rosenthal, M., Isakovic, A., & Marra, C. A. (2011). Pharmacy owner and manager perceptions of pharmacy adaptation services in British Columbia. Canadian Pharmacists Journal, 144(5), 231-235. doi: 10.3821/1913-701X-144.5.231

Wang, M., Fitzgerald, J. M., Richardson, K., Marra, C. A., Cook, V. J., Hajek, J., … Marra, F. (2011). Is the delay in diagnosis of pulmonary tuberculosis related to exposure to fluoroquinolones or any antibiotic? International Journal of Tuberculosis & Lung Disease, 15(8), 1062-1068. doi: 10.5588/ijtld.10.0734

More publications...